miR-125a-3p inhibits ERα transactivation and overrides tamoxifen resistance by targeting CDK3 in estrogen receptor–positive breast cancer
出版年份 2018 全文链接
标题
miR-125a-3p inhibits ERα transactivation and overrides tamoxifen resistance by targeting CDK3 in estrogen receptor–positive breast cancer
作者
关键词
-
出版物
FASEB JOURNAL
Volume 32, Issue 2, Pages 588-600
出版商
FASEB
发表日期
2017-09-23
DOI
10.1096/fj.201700461rr
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Competing endogenous RNA networks of CYP4Z1 and pseudogene CYP4Z2P confer tamoxifen resistance in breast cancer
- (2016) Lufeng Zheng et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Expression of the Long Non-Coding RNA HOTAIR Correlates with Disease Progression in Bladder Cancer and Is Contained in Bladder Cancer Patient Urinary Exosomes
- (2016) Claudia Berrondo et al. PLoS One
- miR-125a-3p targets MTA1 to suppress NSCLC cell proliferation, migration, and invasion
- (2015) Hong Zhang et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- MiRNA-125a-5p inhibits glioblastoma cell proliferation and promotes cell differentiation by targeting TAZ
- (2015) Jian Yuan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4
- (2015) Aamir Ahmad et al. BMC CANCER
- The 3′UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1
- (2015) Lufeng Zheng et al. BREAST CANCER RESEARCH AND TREATMENT
- MiR-214 increases the sensitivity of breast cancer cells to tamoxifen and fulvestrant through inhibition of autophagy
- (2015) Xinfeng Yu et al. Molecular Cancer
- Erratum: MiR-873 regulates ERα transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells
- (2015) J Cui et al. ONCOGENE
- MicroRNA-320a sensitizes tamoxifen-resistant breast cancer cells to tamoxifen by targeting ARPP-19 and ERRγ*
- (2015) Mingrong Lü et al. Scientific Reports
- MiR-125a-3p Regulates Glioma Apoptosis and Invasion by Regulating Nrg1
- (2015) Feng Yin et al. PLoS One
- HITS-CLIP reveals key regulators of nuclear receptor signaling in breast cancer
- (2014) Manoj M. Pillai et al. BREAST CANCER RESEARCH AND TREATMENT
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer
- (2014) Aoife Ward et al. JOURNAL OF PATHOLOGY
- miRNA Dysregulation in Breast Cancer
- (2013) L. Mulrane et al. CANCER RESEARCH
- microRNA-125a-3p reduces cell proliferation and migration by targeting Fyn
- (2013) L. Ninio-Many et al. JOURNAL OF CELL SCIENCE
- Cross-talk between HER2 and MED1 Regulates Tamoxifen Resistance of Human Breast Cancer Cells
- (2012) J. Cui et al. CANCER RESEARCH
- Clinical Applications for microRNAs in Cancer
- (2012) S P Nana-Sinkam et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- miRNAs and estrogen action
- (2012) Carolyn M. Klinge TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Global Characterization of the SRC-1 Transcriptome Identifies ADAM22 as an ER-Independent Mediator of Endocrine-Resistant Breast Cancer
- (2011) D. McCartan et al. CANCER RESEARCH
- MicroRNA-125a-5p Is an Independent Prognostic Factor in Gastric Cancer and Inhibits the Proliferation of Human Gastric Cancer Cells in Combination with Trastuzumab
- (2011) N. Nishida et al. CLINICAL CANCER RESEARCH
- Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells
- (2010) Lili Jiang et al. BMC CANCER
- Roscovitine, a selective CDK inhibitor, reduces the basal and estrogen-induced phosphorylation of ER-α in human ER-positive breast cancer cells
- (2010) Józefa Węsierska-Gądek et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial
- (2010) Jack Cuzick et al. LANCET ONCOLOGY
- Fyn is induced by Ras/PI3K/Akt signaling and is required for enhanced invasion/migration
- (2010) Vipin Yadav et al. MOLECULAR CARCINOGENESIS
- MicroRNA-125a represses cell growth by targeting HuR in breast cancer
- (2010) Xun Guo et al. RNA Biology
- Epidermal growth factor receptor-regulated miR-125a-5p - a metastatic inhibitor of lung cancer
- (2009) Guofu Wang et al. FEBS Journal
- Germline mutation of microRNA-125a is associated with breast cancer
- (2009) W Li et al. JOURNAL OF MEDICAL GENETICS
- Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization
- (2008) M. A. Qadir et al. BREAST CANCER RESEARCH AND TREATMENT
- Cyclin-Dependent Kinase-3-Mediated c-Jun Phosphorylation at Ser63 and Ser73 Enhances Cell Transformation
- (2008) Y.-Y. Cho et al. CANCER RESEARCH
- MicroRNA Expression Profiles in Serous Ovarian Carcinoma
- (2008) E. J. Nam et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started